|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Combined oral and enema treatment with Pentasa(mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis:a randomised,double blind,placebo controlled study显示文摘 | Marteau P Probert CS Lincigren S | 2005 | Gut2005，54，7： | 1 |
| 2 | Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroidresistant ulcerative colitis显示文摘 | Creed TJ Norman MR Probert CS | | 0，，： | 1 |
| 3 | Combine oral and enema treatment with pentasa(mesalazine) is superior to oral therapy 'alone in patients with extensive mild/mederate active ulcerative colitis: a ran- domized, double blind, placebo controlled study 显示文摘 | Marteau P Probert CS Lindgren S | 2005 | Gut2005，54，7： | 1 |
| 4 | Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis:a randomised,double blind,placebo controlled study显示文摘 | Marteau P Probert CS Lindgren S | 2005 | Gut2005，54，7： | 1 |
| 5 | Combined oral and enema treatment with Pentasa(mesalazine) is superior to oral therapy alone in patients with extensive mild moderate active ulcerative colitis:A randomised,double blind,placebo controlled study显示文摘 | Marteau P Probert CS Lindgren S | 2005 | Gut2005，54，7： | 1 |
| 6 | Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis:a randomised,double blind,placebo controlled study显示文摘 | Marteau P Probert CS Lindgren S | 2005 | Gut2005，54，7： | 1 |
| 7 | Basiliximab (anti-CD25) in combination with steroids,may be an effective new treatment for steroid-resistant ulcerative colitis显示文摘 | GREED TJ NORMAN MR PROBERT CS | 2003 | Aliment Pharmacol Ther2003，18，： | 1 |
| 8 | Combined oral and enema treatment with Pentasa (mesalazine)is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis:a randomised,double blind, placebo controlled study显示文摘 | Marteau P Probert CS Lindgren S | 2005 | Gut2005，54，7： | 1 |
| 9 | Combined oral and enema treatment with Pen- tasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study 显示文摘 | Marteau P Probert CS Lindgren S | 2005 | Gut2005，54，7： | 1 |
| 10 | Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis:Rapid symptom remlution and improvements in quality of life 显示文摘 | Probert CS Dignass AU Lindgren S | 2014 | J Crohns CoIitis2014，8，3： | 1 |
| 11 | Information requirements and sedation preferences of patients undergoing endoscopy of the upper gastrointestinal tract显示文摘 | Probert CS Jayanthi V Quinn J | 1991 | Endoscopy1991，23，4： | 1 |
| 12 | Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised con- trolled trial 显示文摘 | Probert CS Hearing SD Schreiber S | 2003 | Gut2003，52，7： | 1 |
| 13 | Combined oral and ene ma treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo con trolled study显示文摘 | Marteau P Probert CS Lindgren S | 2005 | Gut2005，54，7： | 1 |
| 14 | Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis : a retrospective study of colorectal cancer risk and compliance with treat- ment in Leicestershire 显示文摘 | Moody GA Jayanthi V Probert CS | 1996 | Eur J Gastroenterol Hepatol1996，8，12： | 1 |
| 15 | Terminal beta - linked tyvelose creates unique epitopes in Trichinella spiralis glycan antigens 显示文摘 | McVay CS Probert MA | 1997 | Glycobiology1997，7，： | 1 |
| 16 | Long - term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis : a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire 显示文摘 | Moody GA Jayanthi V Probert CS | 1996 | Eur J Gastroenterol Hepatol1996，8，： | 1 |
| 17 | Audit of cyclosporin use in inflammatory bowel disease:limited benefits,numerous sideeffects显示文摘 | Haslam N Hearing SD Probert CS | 2000 | EurJ Gastroenterol Hepatol2000，12，： | 1 |
| 18 | Infliximab in moderately severe glococorticoid resistant ulcerative colitis: a randomized controlled trial 显示文摘 | Probert CS Hearing SD Schreiber S | 2003 | Gut2003，52，7： | 1 |
| 19 | Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes显示文摘 | Heating SD Norman M Probert CS | 1999 | Gut1999，45，3： | 1 |
| 20 | Information requirements and sedation preferences of patients undergoing endoscopy of the upper gastrointestinal tract显示文摘 | Probert CS Jayanthi V Quinn J | 1991 | Endoscopy1991，23，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员